CLINICAL_TRIALS
safety_alert
· 2013-10-16
Clinical Trial Update: Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction [Phase 4]
Summary
Phase 4 trial update evaluating renal toxicity risk of iodixanol and iopromide in patients with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yong Huo | Conditions: Kidney Failure, Chronic | Phase 4 | Status: UNKNOWN